Clinical Trials Directory

Trials / Unknown

UnknownNCT03589092

Genetic Causes of Gestational Diabetes in the Emirati Population

Status
Unknown
Phase
Study type
Observational
Enrollment
600 (estimated)
Sponsor
Imperial College London Diabetes Centre · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The study aims to identify the number of MODY patients to be found among Emirati women with GDM as the incidence and prevalence of monogenic diabetes among this group of patients is unknown. This will enable improvements in diagnostics, treatment and the counselling of these women.

Detailed description

The present study aims to perform systematic genetic screening of genes known as the cause of MODY in women diagnosed with gestational diabetes to estimate the prevalence of MODY. This is important to understand the extent to which monogenic diabetes is encountered for the first time during pregnancy. Once women with MODY developing GDM have been identified, biomarkers to identify these women can be found which will assist the clinical process of performing genetic screening in the right subset of patients. Also for the women participating in the present study, this is of great importance as correct genetic diagnosis will provide them with the needed information to receive optimal treatment, correct plan for follow-up and a more accurate prognosis in relation to risk of future complication and therefore prevention of such.

Conditions

Interventions

TypeNameDescription
GENETICNext generation sequencing (NGS)NGS Panel, Whole exome/genome sequencing

Timeline

Start date
2017-01-01
Primary completion
2020-12-31
Completion
2020-12-31
First posted
2018-07-17
Last updated
2020-06-25

Locations

1 site across 1 country: United Arab Emirates

Source: ClinicalTrials.gov record NCT03589092. Inclusion in this directory is not an endorsement.